# Retreatment of Recurrent Dupuytren's Contractures

> **NCT01498640** · PHASE4 · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 52 (actual)

## Conditions studied

- Dupuytren's Disease

## Interventions

- **BIOLOGICAL:** Collagenase clostridium histolyticum

## Key facts

- **NCT ID:** NCT01498640
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2017-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01498640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01498640, "Retreatment of Recurrent Dupuytren's Contractures". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01498640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*